臺大學術典藏 |
2018-09-10T09:27:24Z |
Pharmacotherapy of Osteoporosis
|
RONG-SEN YANG; RONG-SEN YANG |
國立臺灣大學 |
2008 |
Pharmacotherapy of Post-Transplant Viral Infections
|
孫幸筠; SUN, HSIN-YUN |
臺大學術典藏 |
2008 |
Pharmacotherapy of post-transplant viral infections
|
Sun, H.-Y. and Singh, N.; HSIN-YUN SUN |
臺大學術典藏 |
2008 |
Pharmacotherapy of post-transplant viral infections
|
Hsin-Yun Sun;Singh N.; HSIN-YUN SUN; Singh N. |
臺北醫學大學 |
2014 |
Pharmacy profession in India: Current scenario and Recommendations
|
Ahmad, Akram;Atique, Suleman;Balkrishnan, Rajesh;Patel, Isha |
嘉南藥理大學 |
1999 |
Pharmalokinetic Behavior of Atenolol in Adult Chinese Males
|
莊禮維 |
高雄醫學大學 |
2016 |
Pharmarcogenetic mechanism of ACE I/D polymorphism adversely responding to ACE inhibitors in regulating the ACE promoter activity in neurons
|
楊淵韓;張學偉;張偉嶠;施昱丞;蔡克勵;簡薏;吳世忠 |
中國醫藥大學 |
1997-08 |
Pharmcological Studies on Niuxi Species in Taiwan.
|
(Chang Y.S.); (Y.L. Ho); 蔡輝彥(H.Y. Tsai); (M.T. Hsieh); (C.C. Chang) |
亞洲大學 |
2006 |
Pharmocogenetic study on efficacy of recombinant growth hormone treatment in short stature patients with growth hormone deficiency
|
Wei-Cheng Chen |
中國醫藥大學 |
2006-03-18 |
Pharmocogenetic study on efficacy of recombinant growth hormone treatment in short stature patients with growth hormone deficiency
|
陳威成(Wei-Cheng Chen); 蔡輔仁(Fuu-Jen Tsai); 萬磊(Lei Wan) |
臺大學術典藏 |
2018-09-10T18:03:25Z |
Pharyngeal airway changes following maxillary expansion or protraction: A meta-analysis
|
Lee, W.-C. ; Tu, Y.-K. ; Huang, C.-S. ; Chen, R. ; Fu, M.-W. ; Fu, E.; YU-KANG TU |
臺大學術典藏 |
2022-05-10T08:10:02Z |
Pharyngeal airway changes following maxillary expansion or protraction: A meta-analysis
|
Lee W.-C.; YU-KANG TU; Huang C.-S.; Chen R.; Fu M.-W.; Fu E. |
國立臺灣大學 |
2004 |
Pharyngeal-Brachial Palsy after Cytomegalovirus Colitis
|
潘俊良; 孫家棟; 謝松蒼; PAN, CHUN-LIANG; SHUN, CHIA-TUNG; SUSUKI K.; YUKI N.; HSIEH, SUNG-TSANG |
臺大學術典藏 |
2018-09-10T05:01:24Z |
Pharyngeal-brachial palsy after cytomegalovirus colitis
|
Pan, C.-L. and Shun, C.-T. and Susuki, K. and Yuki, N. and Hsieh, S.-T.; SUNG-TSANG HSIEH |
臺大學術典藏 |
2020-03-02T08:11:29Z |
Pharyngeal-brachial palsy after cytomegalovirus colitis
|
Pan C.-L.;Shun C.-T.;Susuki K.;Yuki N.;Sung-Tsang Hsieh; Pan C.-L.; Shun C.-T.; Susuki K.; Yuki N.; SUNG-TSANG HSIEH |
臺大學術典藏 |
2021-03-18T02:03:24Z |
Pharyngeal-brachial palsy after cytomegalovirus colitis
|
Pan C.-L.;Chia-Tung Shun;Susuki K.;Yuki N.;Hsieh S.-T.; Pan C.-L.; CHIA-TUNG SHUN; Susuki K.; Yuki N.; Hsieh S.-T. |
臺大學術典藏 |
2021-05-31T05:59:17Z |
Pharyngeal-brachial palsy after cytomegalovirus colitis
|
CHUN-LIANG PAN; Shun C.-T.; Susuki K.; Yuki N.; Hsieh S.-T. |
元智大學 |
2015-11-05 |
PHAs surface modification by plasma technology
|
Chih-Kai Chang; Chi-Wei (John) Lan; Hui-Min David Wang |
國家衛生研究院 |
2023-06 |
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors
|
Lin, CC;Chiang, NJ;Lee, JH;Chen, MH;Chao, Y;Su, WC;Bai, LY;Wu, SY;Hsu, CH;Shan, YS;Li, CP;Chen, SH;Chung, WP;Chen, LT |
臺大學術典藏 |
2020-05-25T07:35:01Z |
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
|
Chia-Chi Lin; Akimov M; Ghebremariam S; Hong D; Poon R.T.P; Azaro A; Lim W.T; Bauer T.M; Nam D.-H; Schuler M; Su W.-C; Bang Y.-J; Zhao S; Giovannini M; Ma B. |
臺大學術典藏 |
2022-09-15T01:09:00Z |
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
|
Bang Y.-J.; Su W.-C.; Schuler M.; Nam D.-H.; Lim W.T.; Bauer T.M.; Azaro A.; Poon R.T.P.; Hong D.; Chia-Chi Lin; Akimov M.; Ghebremariam S.; Zhao S.; Giovannini M.; Ma B. |
國立成功大學 |
2020 |
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
|
Bang, Y.-J.;Su, W.-C.;Schuler, M.;Nam, D.-H.;Lim, W.T.;Bauer, T.M.;Azaro, Azaro A.;Poon, R.T.P.;Hong, D.;Lin, C.-C.;Akimov, M.;Ghebremariam, S.;Zhao, S.;Giovannini, M.;Ma, B. |
國家衛生研究院 |
2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors
|
Bai, LY;Chiang, NJ;Hsu, CH;Liang, YH;Chiu, CF;Lin, CC;Chang, KY;Chen, SH;Tsai, HJ;Lin, YP;Chen, LT;Lin, CC |
國立臺灣大學 |
2015 |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊 |
臺大學術典藏 |
2020-05-25T07:35:20Z |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: Pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan K; Kim T.M; Chia-Chi Lin; Thye L.S; Chng W.J; Ma B; Chen M.H; Zhou X; Liu H; Kelly V; Kim W.S. |